Over the last several years, NAMSA has collaborated with various global neurology manufacturers to achieve, cost-efficient, accelerated development and commercialization outcomes for products ranging from: hydrocephalus shunts; interventional neuroradiology; neuromodulation; neurosurgical products; radiosurgery systems; minimally invasive neurosurgery; neurological diagnostic; and monitoring equipment.
NAMSA has performed a wide variety and number of biological safety studies, and over 200 customized preclinical studies on neurological devices. In addition, our team of global clinical research experts have conducted the following clinical studies over the last few years: